Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

1.15
Delayed Data
As of Aug 28
 0.00 / 0.00%
Today’s Change
1.00
Today|||52-Week Range
1.75
-17.27%
Year-to-Date

Today’s Trading

Previous close1.15
Today’s open1.15
Day’s range1.14 - 1.17
Volume738,114
Average volume (3 months)1,140,001
Market cap$231.3M
Dividend yield--
Data as of 08/28/2015

Growth & Valuation

Earnings growth (last year)-36.36%
Earnings growth (this year)-3.33%
Earnings growth (next 5 years)--
Revenue growth (last year)+19.55%
P/E ratioNM
Price/Sales8.93
Price/Book3.77

Competitors

 Today’s
change
Today’s
% change
CORICorium International...-0.27-2.52%
DRNADicerna Pharmaceutic...+0.89+8.69%
ASMBAssembly Biosciences...+0.36+2.78%
NVLSNivalis Therapeutics...-0.24-1.55%
Data as of 08/28/2015

Financials

Next reporting dateSeptember 7, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$26.8M
Annual profit (last year)-$50.4M
Net profit margin-188.04%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts

Partner Offers